// App-Quantinova.ai

835 : Generation of an Efficient CRISPR-Cas9 Editing Technique in Human Primary B Cells for the Targeted Study of Autoimmune Susceptibility Genes

Researchers

Presenter

  • Yuriy Baglaenko

Principal Investigators

  • Dario Ferri

  • Juan Carlos Zuniga-Pflucker

  • Joan E. Wither

Medical Centers

  • Genetics and Development, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

  • Biological Sciences Platform, Sunnybrook Research Institute, Toronto, ON, Canada

  • Rheumatology, Toronto Western Research Institute. University of Toronto, Toronto, ON, Canada

  • Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • B-cell activating factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved